Average Co-Inventor Count = 14.86
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (14 from 378 patents)
2. Bayer Aktiengesellschaft (13 from 12,167 patents)
3. The Broad Institute, Inc. (9 from 445 patents)
4. Other (1 from 832,966 patents)
5. Dana-Farber-Cancer Institute Inc. (1 from 1,211 patents)
16 patents:
1. 12227501 - 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors
2. 12152041 - Macrocyclic fluorine substituted indole derivatives
3. 11891404 - Substituted macrocyclic indole derivatives
4. 11691986 - PTEFB inhibiting macrocyclic compounds
5. 11492358 - Macrocyclic indole derivatives
6. 11478451 - Macrocyclic chlorine substituted indole derivatives
7. 11447504 - Macrocyclic chlorine substituted indole derivatives
8. 11440923 - Substituted macrocyclic indole derivatives
9. 11401278 - Macrocyclic indole derivatives
10. 11286263 - Macrocyclic fluorine substituted indole derivatives
11. 11254690 - PTEFb inhibiting macrocyclic compounds
12. 11242356 - PTEFb inhibiting macrocyclic compounds
13. 11161825 - 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides
14. 10981932 - Macrocyclic indole derivatives
15. 10894784 - Heteroarylbenzimidazole compounds